See also this year's filing and all EDGAR filings for this company.
PDF Report 0001173313_2026_ABVC_Biopharma_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001173313, ABVC Biopharma INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 2,501,343 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 12,835,409 |
| 3 | remainder_Assets | 5,725,451 |
| 4 | LiabilitiesCurrent | 6,163,976 |
| 5 | LiabilitiesNoncurrent | 1,600,747 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 17.0 |
| 8 | SellingGeneralAndAdministrativeExpense | 3,101,834 |
| 9 | ResearchAndDevelopmentExpense | 120,168 |
| 10 | remainder_Expenses | 4,123,371 |
| 11 | remainder_Revenues | 237,190 |
| 12 | remainder_NetIncome | -1,021,513 |
| 13 | remainder_ComprehensiveNetIncome | 448,059 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 21,062,203 |
| 1 | Liabilities | 7,764,723 |
| 2 | Expenses | 7,345,390 |
| 3 | Revenues | 237,190 |
| 4 | StockholdersEquity | 13,297,480 |
| 5 | NetIncome | -8,129,713 |
| 6 | ComprehensiveNetIncome | -7,905,684 |
| 7 | BaseVar | 18,939,539 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.46 |
| 9 | EconomicCapitalRatio | 2.65 |
Edgar->Model Mapping
Feature Distribution
Change over Time
